Shandong Polymer Biochemicals Co., Ltd.
Symbool: 002476.SZ
SHZ
4.61
CNYMarktprijs vandaag
-1078.4464
Koers/Winst Verhouding
12.5889
Koers/Winst Groei Verhouding
2.82B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1259.11 | 305.6 | 401 | 361.8 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0.31 | 0.3 | 0 | -18.6 | ||||||||||||||||
balance-sheet.row.net-receivables | 1010.97 | 365.1 | 248.1 | 127.9 | ||||||||||||||||
balance-sheet.row.inventory | 426.51 | 84.5 | 82 | 65.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 15.57 | 6.6 | 24.1 | 13.5 | ||||||||||||||||
balance-sheet.row.total-current-assets | 2712.15 | 761.7 | 755.1 | 568.9 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 745.39 | 182.4 | 200.8 | 390 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 278.39 | 79.5 | 8.5 | 31.5 | ||||||||||||||||
balance-sheet.row.tax-assets | 20.63 | 5.8 | 6.5 | 7.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 24.19 | 0.4 | 10.8 | 1.2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 1510.49 | 278.2 | 237.3 | 441.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.account-payables | 262.9 | 134.6 | 63.1 | 58.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 60.91 | 11.4 | 1.4 | 43.1 | ||||||||||||||||
balance-sheet.row.tax-payables | 14.29 | 3.2 | 3.9 | 2.1 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 77.9 | ||||||||||||||||
Deferred Revenue Non Current | 4.77 | 1.3 | 1.5 | 1.7 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.34 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 40.68 | 22.8 | 12 | 0.5 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5.11 | 1.3 | 1.7 | 79.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2.3 | 1.4 | 0.1 | 77.9 | ||||||||||||||||
balance-sheet.row.total-liab | 497.51 | 170.4 | 152.4 | 188 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 2448 | 612 | 612 | 612 | ||||||||||||||||
balance-sheet.row.retained-earnings | 108.28 | 29.1 | -0.5 | -18.5 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 568.62 | 53.5 | 53.5 | 53.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 349.96 | 175 | 175 | 175 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3474.86 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.minority-interest | 250.28 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 3725.13 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4222.64 | - | - | - | ||||||||||||||||
Total Investments | 278.39 | 79.5 | 8.5 | 12.9 | ||||||||||||||||
balance-sheet.row.total-debt | 60.91 | 11.4 | 1.6 | 43.1 | ||||||||||||||||
balance-sheet.row.net-debt | -1198.2 | -294.2 | -399.4 | -318.8 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 9.59 | 34.9 | 38.8 | 40.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0.69 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.7 | 0.2 | -3.9 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -164.92 | -153.9 | -101.8 | -33.6 | ||||||||||||||||
cash-flows.row.account-receivables | -161.99 | -162 | -206.5 | -52.2 | ||||||||||||||||
cash-flows.row.inventory | -2.92 | -2.9 | -15.9 | 25.2 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 10.3 | 120.9 | -10.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 108.17 | 11.2 | 10.2 | 12.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 104.27 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | -71.17 | 5.5 | 117.5 | 2.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -40 | -80 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1.9 | 1.9 | 22.6 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | -65.64 | 0.9 | -1.7 | 24.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -117.35 | -86.7 | 119.5 | 8.8 | ||||||||||||||||
cash-flows.row.debt-repayment | -21.82 | -9.9 | -30.3 | -67 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -0.57 | -0.4 | -5.7 | -10.4 | ||||||||||||||||
cash-flows.row.other-financing-activites | 24.81 | 17.7 | -12 | 7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.15 | 7.3 | -48 | -70.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.91 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -8.02 | -157.6 | 36.6 | -29.1 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1184.3 | 240.6 | 398.2 | 361.5 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1192.32 | 398.2 | 361.5 | 390.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 104.27 | -78.2 | -34.8 | 32.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 92.56 | -93.2 | -54 | 14.9 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 479.79 | 592.3 | 657.2 | 447.3 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 384.21 | 462.7 | 557.1 | 363.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 95.58 | 129.6 | 100.1 | 83.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 18.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.99 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 98.38 | 100.8 | 76.8 | 58.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 482.59 | 563.5 | 633.9 | 421.9 | ||||||||||||||||
income-statement-row.row.interest-income | 6.13 | 6.7 | 5.4 | 5.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -4.07 | 36.9 | 38.8 | 40.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -4.59 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -0.52 | 30.7 | 25.3 | 26.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -2.13 | 31.1 | 17.7 | 17.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -0.07 | 1.4 | -0.2 | 3.9 | ||||||||||||||||
income-statement-row.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 |
Vaak gestelde vragen
Wat is Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) totale activa?
Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) totale activa is 1039968863.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 212096636.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.199.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is -0.004.
Wat is de totale omzet van de onderneming?
De totale opbrengst is -0.001.
Wat is Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) nettowinst (netto-inkomen)?
De nettowinst is 29630378.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 11381167.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 100833128.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 314019731.000.